Neuronal histamine and the interplay of memory, reinforcement and emotions

Behavioural Brain Research

Volumn 215, Issue 2, 2010, Pages 209-220

  Dere, E ^a   Zlomuzica, A ^a   De Souza Silva, M A ^a   Ruocco, L A ^b   Sadile, A G ^b   Huston, J P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acetylcholine; Alzheimer's disease; Episodic memory; Histamine H1 receptor; Histidine decarboxylase; Knockout mice; Nucleus tuberomamillaris

Indexed keywords

4 METHYLHISTAMINE; AMTHAMINE; CHLORPHENIRAMINE; CIPROXIFAN; CLOBENPROPIT; DIMAPRIT; GSK 207040; GSK 334429; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; HISTIDINE; HISTIDINE DECARBOXYLASE; JNJ 10181457; KETOTIFEN; MEMANTINE; MEPYRAMINE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PHYSOSTIGMINE; TACRINE; THIOPERAMIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANXIETY; AROUSAL; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE SEVERITY; DRUG ACTIVITY; EMOTION; EPISODIC MEMORY; FEAR; HISTAMINE METABOLISM; HUMAN; LEARNING DISORDER; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; REWARD; SLEEP;

ANIMALS; BRAIN; EMOTIONS; HISTAMINE; HUMANS; MENTAL RECALL; NEURODEGENERATIVE DISEASES; NEURONS; REINFORCEMENT (PSYCHOLOGY); SYNAPTIC TRANSMISSION;

EID: 77956440768     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.12.045     Document Type: Review

References (166)

1. Acevedo S.F., Ohtsu H., Benice T.S., Rizk-Jackson A., Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc-/-) mice. Brain Res 2006, 1071:113-123.
2. Airaksinen M.S., Paetau A., Paljärvi L., Reinikainen K., Riekkinen P., Suomalainen R., et al. Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 1991, 44:465-481.
3. Airaksinen M.S., Reinikainen K., Riekkinen P., Panula P. Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus. Agents Actions 1991, 33:104-107.
4. Alvarez E.O., Alvarez P.A. Motivated exploratory behaviour in the rat: the role of hippocampus and the histaminergic neurotransmission. Behav Brain Res 2008, 186:118-125.
5. Alvarez E.O., Banzan A.M. Effects of localized histamine microinjections into the hippocampal formation on the retrieval of a one-way active avoidance response in rats. J Neural Transm Gen Sect 1995, 101:201-211.
6. Anichtchik O.V., Rinne J.O., Kalimo H., Panula P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 2000, 163:20-30.
7. Bakker R.A., Schoonus S.B., Smit M.J., Timmerman H., Leurs R. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 2001, 60:1133-1142.
8. Bernaerts P., Lamberty Y., Tirelli E. Histamine H3 antagonist thioperamide dose-dependently enhances memory consolidation and reverses amnesia induced by dizocilpine or scopolamine in a one-trial inhibitory avoidance task in mice. Behav Brain Res 2004, 154:211-219.
9. Bertoni S., Ballabeni V., Flammini L., Saccani F., Domenichini G., Morini G., et al. In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:335-343.
10. Blandina P., Efoudebe M., Cenni G., Mannaioni P., Passani M.B. Acetylcholine, histamine, and cognition: two sides of the same coin. Learn Mem 2004, 11:1-8.
11. Bonaventure P., Letavic M., Dugovic C., Wilson S., Aluisio L., Pudiak C., et al. Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 2007, 73:1084-1096.
12. Brabant C., Quertemont E., Anaclet C., Lin J.S., Ohtsu H., Tirelli E. The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward. Psychopharmacology (Berl) 2007, 190:251-263.
13. Brown R.E., Fedorov N.B., Haas H.L., Reymann K.G. Histaminergic modulation of synaptic plasticity in area CA1 of rat hippocampal slices. Neuropharmacology 1995, 34:181-190.
14. Brown R.E., Haas H.L. On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus. J Physiol 1999, 515:777-786.
15. Cacabelos R., Alvarez X.A. Histidine decarboxylase inhibition induced by alpha-fluoromethylhistidine provokes learning-related hypokinetic activity. Agents Actions 1991, 33:131-134.
16. Cangioli I., Baldi E., Mannaioni P.F., Bucherelli C., Blandina P., Passani M.B. Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release. Eur J Neurosci 2002, 16:521-528.
17. Chen Z., Shen Y.J. Effects of brain histamine on memory deficit induced by nucleus basalis-lesion in rats. Acta Pharmacol Sin 2002, 23:66-70.
18. Chen Z., Sugimoto Y., Kamei C. Effects of intracerebroventricular injection of alpha-fluoromethylhistidine on radial maze performance in rats. Pharmacol Biochem Behav 1999, 64:513-518.
19. Chen Z., Chen J.Q., Kamei C. Effect of H1-antagonists on spatial memory deficit evaluated by 8-arm radial maze in rats. Acta Pharmacol Sin 2001, 22:609-613.
20. Cumming P., Reiner P.B., Vincent S.R. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA). Biochem Pharmacol 1990, 40:1345-1350.
21. da Silva W.C., Bonini J.S., Bevilaqua L.R., Izquierdo I., Cammarota M. Histamine enhances inhibitory avoidance memory consolidation through a H2 receptor-dependent mechanism. Neurobiol Learn Mem 2006, 86:100-106.
22. Dai H., Kaneko K., Kato H., Fujii S., Jing Y., Xu A., et al. Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neurosci Res 2007, 57:306-313.
23. de Almeida M.A., Izquierdo I. Memory facilitation by histamine. Arch Int Pharmacodyn Ther 1986, 283:193-198.
24. de Almeida M.A., Izquierdo I. Intracerebroventricular histamine, but not 48/80, causes posttraining memory facilitation in the rat. Arch Int Pharmacodyn Ther 1988, 291:202-207.
25. Dere E., De Souza Silva M.A., Huston J.P. Higher order memories for objects encountered in different spatio-temporal contexts in mice: evidence for episodic memory. Rev Neurosci 2004, 15:231-240.
26. Dere E., De Souza-Silva M.A., Topic B., Spieler R.E., Haas H.L., Huston J.P. Histidine-decarboxylase knockout mice show deficient nonreinforced episodic object memory, improved negatively reinforced water-maze performance, and increased neo- and ventro-striatal dopamine turnover. Learn Mem 2003, 10:510-519.
27. Dere E., De Souza-Silva M.A., Spieler R.E., Lin J.S., Ohtsu H., Haas H.L., et al. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur J Neurosci 2004, 20:1051-1058.
28. Dere E., Zlomuzica A., Huston J.P., De Souza Silva M.A. Animal episodic memory. Handbook of Episodic Memory 2008, vol. 18:155-184. Elsevier Science, Amsterdam, Chapter 2.2.
29. Dere E., Zlomuzica A., Viggiano D., Ruocco L.A., Watanabe T., Sadile A.G., et al. Episodic-like and procedural memory impairments in histamine H1 receptor knockout mice coincide with changes in acetylcholine esterase activity in the hippocampus and dopamine turnover in the cerebellum. Neuroscience 2008, 157:532-541.
30. Dringenberg H.C., De Souza-Silva M.A., Rossmüller J., Huston J.P., Schwarting R.K. Histamine H1 receptor antagonists produce increases in extracellular acetylcholine in rat frontal cortex and hippocampus. J Neurochem 1998, 70:1750-1758.
31. Dringenberg H.C., de Souza-Silva M.A., Schwarting R.K., Huston J.P. Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade. Naunyn Schmiedebergs Arch Pharmacol 1998, 358:423-429.
32. Dringenberg H.C., Kuo M.C. Cholinergic, histaminergic, and noradrenergic regulation of LTP stability and induction threshold: cognitive implications. EXS 2006, 98:165-183.
33. Eggers C., Herholz K., Kalbe E., Heiss W.D. Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease. Neurosci Lett 2006, 408:46-50.
34. Esbenshade T.A., Browman K.E., Bitner R.S., Strakhova M., Cowart M.D., Brioni J.D. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol 2008, 154:1166-1181.
35. Esbenshade T.A., Fox G.B., Cowart M.D. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders. Mol Interv 2006, 6:77-88.
36. Fernández-Novoa L., Cacabelos R. Histamine function in brain disorders. Behav Brain Res 2001, 124:213-233.
37. Fibiger H.C., Phillips A.G. Mesocorticolimbic dopamine systems and reward. Ann N Y Acad Sci 1988, 537:206-215.
38. Fleckenstein A.E., Lookingland K.J., Moore K.E. Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors. Naunyn Schmiedebergs Arch Pharmacol 1993, 347:50-54.
39. Fliessbach K., Trautner P., Quesada C.M., Elger C.E., Weber B. Cerebellar contributions to episodic memory encoding as revealed by fMRI. Neuroimage 2007, 35:1330-1337.
40. Flood J.F., Uezu K., Morley J.E. Effect of histamine H2 and H3 receptor modulation in the septum on post-training memory processing. Psychopharmacology (Berl) 1998, 140:279-284.
41. Frisch C., Hasenöhrl R.U., Haas H.L., Weiler H.T., Steinbusch H.W., Huston J.P. Facilitation of learning after lesions of the tuberomammillary nucleus region in adult and aged rats. Exp Brain Res 1998, 118:447-456.
42. Frisch C., Hasenöhrl R.U., Krauth J., Huston J.P. Anxiolytic-like behavior after lesion of the tuberomammillary nucleus E2-region. Exp Brain Res 1998, 119:260-264.
43. Frisch C., Hasenöhrl R.U., Huston J.P. Memory improvement by post-trial injection of lidocaine into the tuberomammillary nucleus, the source of neuronal histamine. Neurobiol Learn Mem 1999, 72:69-77.
44. Fu Q.L., Dai H.B., Shen Y., Chen Z. Reversing effect of histamine on neurotoxicity induced by beta-amyloid1-42. Zhejiang Da Xue Xue Bao Yi Xue Ban 2007, 36:146-149.
45. Galici R., Boggs J.D., Aluisio L., Fraser I.C., Bonaventure P., Lord B., et al. JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition. Neuropharmacology 2009, 56:1131-1137.
46. Galosi R., Lenard L., Knoche A., Haas H., Huston J.P., Schwarting R.K. Dopaminergic effects of histamine administration in the nucleus accumbens and the impact of H1-receptor blockade. Neuropharmacology 2001, 40:624-633.
47. Giovannini M.G., Efoudebe M., Passani M.B., Baldi E., Bucherelli C., Giachi F., et al. Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells. J Neurosci 2003, 23:9016-9023.
48. Gong Y.X., Zhang W.P., Shou W.T., Zhong K., Chen Z. Morphine induces conditioned place preference behavior in histidine decarboxylase knockout mice. Neurosci Lett 2010, 468:115-119.
49. Gorelova N., Reiner P.B. Histamine depolarizes cholinergic septal neurons. J Neurophysiol 1996, (75):707-714.
50. Grön G., Bittner D., Schmitz B., Wunderlich A.P., Riepe M.W. Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder. Ann Neurol 2002, 51:491-498.
51. Haas H., Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003, 4:121-130.
52. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol Rev 2008, 88:1183-1241.
53. Haas H.L., Sergueeva O.A., Vorobjev V.S., Sharonova I.N. Subcortical modulation of synaptic plasticity in the hippocampus. Behav Brain Res 1995, 66:41-44.
54. Hancock A.A., Fox G.B. Perspectives on cognitive domains. H3 receptor ligands and neurological disease. Expert Opin Invest Drugs 2004, 13:1237-1248.
55. Hasenöhrl R.U., Huston J.P. Histamine. Memories are made of these: from messengers to molecules 2004, Landes Bioscience, Chapter 2.8. G. Riedel, B. Platt (Eds.).
56. Hasenöhrl R.U., Kuhlen A., Frisch C., Galosi R., Brãndao M.L., Huston J.P. Comparison of intra-accumbens injection of histamine with histamine H1-receptor antagonist chlorpheniramine in effects on reinforcement and memory parameters. Behav Brain Res 2001, 124:203-211.
57. Hasenöhrl R.U., Weth K., Huston J.P. Intraventricular infusion of the histamine H(1) receptor antagonist chlorpheniramine improves maze performance and has anxiolytic-like effects in aged hybrid Fischer 344xBrown Norway rats. Exp Brain Res 1999, 128:435-440.
58. Hasselmo M.E. The role of acetylcholine in learning and memory. Curr Opin Neurobiol 2006, 16:710-715.
59. Hasselmo M.E., Wyble B.P., Wallenstein G.V. Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus 1996, 6:693-708.
60. Henwood R.W., Mazurikiewicz-Kwilecki I.M. Possible role of brain histamine in morphine addiction. Life Sci 1975, 17:55-56.
61. Herholz K., Weisenbach S., Kalbe E., Diederich N.J., Heiss W.D. Cerebral acetylcholine esterase activity in mild cognitive impairment. Neuroreport 2005, 16:1431-1434.
62. Higuchi M., Yanai K., Okamura N., Meguro K., Arai H., Itoh M., et al. Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 2000, 99:721-729.
63. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997, 49:253-278.
64. Hindmarch I., Shamsi Z. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers. Curr Med Res Opin 2001, 17:273-281.
65. Hotte M., Naudon L., Jay T.M. Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats. Neurobiol Learn Mem 2005, 84:85-92.
66. Huang Y.W., Chen Z., Hu W.W., Zhang L.S., Wu W., Ying L.Y., et al. Facilitating effect of histamine on spatial memory deficits induced by dizocilpine as evaluated by 8-arm radial maze in SD rats. Acta Pharmacol Sin 2003, 24:1270-1276.
67. Huang Y.W., Hu W.W., Chen Z., Zhang L.S., Shen H.Q., Timmerman H., et al. Effect of the histamine H3-antagonist clobenpropit on spatial memory deficits induced by MK-801 as evaluated by radial maze in Sprague-Dawley rats. Behav Brain Res 2004, 151:287-293.
68. Huang Z.L., Mochizuki T., Qu W.M., Hong Z.Y., Watanabe T., Urade Y., et al. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A 2006, 103:4687-4692.
69. Huang Z.L., Qu W.M., Li W.D., Mochizuki T., Eguchi N., Watanabe T., et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001, 98:9965-9970.
70. Huston J.P., Mondadori C. Reinforcement and memory: a model [proceedings]. Act Nerv Super (Praha) 1977, 19:17-19.
71. Huston J.P., Oitzl M.S. The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P. Neurosci Biobehav Rev 1989, 13:171-180.
72. Huston J.P., Wagner U., Hasenöhrl R.U. The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res 1997, 83:97-105.
73. Inoue I., Yanai K., Kitamura D., Taniuchi I., Kobayashi T., Niimura K., et al. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc Natl Acad Sci U S A 1996, 93:13316-13320.
74. Ishunina T.A., van Heerikhuize J.J., Ravid R., Swaab D.F. Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex, aging and Alzheimer's disease. Brain Res 2003, 988:84-96.
75. Ito C. The role of brain histamine in acute and chronic stresses. Biomed Pharmacother 2000, 54:263-267.
76. Jiang X., Chen A., Li H. Histaminergic modulation of excitatory synaptic transmission in the rat basolateral amygdala. Neuroscience 2005, 131:691-703.
77. Josselyn S.A., Nguyen P.V. CREB, synapses and memory disorders: past progress and future challenges. Curr Drug Targets CNS Neurol Disord 2005, 4:481-497.
78. Kamei C., Chen Z., Nakamura S., Sugimoto Y. Effects of intracerebroventricular injection of histamine on memory deficits induced by hippocampal lesions in rats. Methods Find Exp Clin Pharmacol 1997, 19:253-259.
79. Kamei C., Okumura Y., Tasaka K. Influence of histamine depletion on learning and memory recollection in rats. Psychopharmacology (Berl) 1993, 111:376-382.
80. Kamei C., Tasaka K. Effect of histamine on memory retrieval in old rats. Biol Pharm Bull 1993, 16:128-132.
81. Khateb A., Fort P., Pegna A., Jones B.E., Mühlethaler M. Cholinergic nucleus basalis neurons are excited by histamine in vitro. Neuroscience 1995, 69:495-506.
82. Kim S.H., Cairns N., Fountoulakisc M., Lubec G. Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease. Neurosci Lett 2001, 300:41-44.
83. Knoche A., Yokoyama H., Ponomarenko A., Frisch C., Huston J., Haas H.L. High-frequency oscillation in the hippocampus of the behaving rat and its modulation by the histaminergic system. Hippocampus 2003, 13:273-280.
84. Korotkova T.M., Haas H.L., Brown R.E. Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro. Neurosci Lett 2002, 320:133-136.
85. Kubota Y., Ito C., Sakurai E., Sakurai E., Watanabe T., Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. J Neurochem 2002, 83:837-845.
86. Kuo M.C., Dringenberg H.C. Histamine facilitates in vivo thalamocortical long-term potentiation in the mature visual cortex of anesthetized rats. Eur J Neurosci 2008, 27:1731-1738.
87. Lahmeyer H.W., Steingold R.G. Medical and psychiatric complications of pentazocine and tripelennamine abuse. J Clin Psychiatry 1980, 41:275-278.
88. Lalonde R., Hannequin D. The neurobiological basis of time estimation and temporal order. Rev Neurosci 1999, 10:151-173.
89. Ligneau X., Perrin D., Landais L., Camelin J.C., Calmels T.P., Berrebi-Bertrand I., et al. BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: preclinical pharmacology. J Pharmacol Exp Ther 2007, 320:365-375.
90. Lin J.S. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med Rev 2000, 4:471-503.
91. Lin J.S., Hou Y., Sakai K., Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 1996, 16:1523-1537.
92. Lin J.S., Sakai K., Vanni-Mercier G., Jouvet M. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 1989, 479:225-240.
93. Lintunen M., Sallmen T., Karlstedt K., Fukui H., Eriksson K.S., Panula P. Postnatal expression of H1-receptor mRNA in the rat brain: correlation to L-histidine decarboxylase expression and local upregulation in limbic seizures. Eur J Neurosci 1998, 10:2287-2301.
94. Liu C., Ma X., Jiang X., Wilson S.J., Hofstra C.L., Blevitt J., et al. Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol Pharmacol 2001, 59:420-426.
95. Liu L., Zhang S., Zhu Y., Fu Q., Zhu Y., Gong Y., et al. Improved learning and memory of contextual fear conditioning and hippocampal CA1 long-term potentiation in histidine decarboxylase knock-out mice. Hippocampus 2007, 17:634-641.
96. Lynch M.A. Long-term potentiation and memory. Physiol Rev 2004, 84:87-136.
97. Maisonnette S., Huston J.P., Brandao M., Schwarting R.K. Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra. Exp Brain Res 1998, 120:273-282.
98. Malmberg-Aiello P., Ipponi A., Bartolini A., Schunack W. Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol Biochem Behav 2002, 71:313-318.
99. Masukawa Y., Suzuki T., Misawa M. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology (Berl) 1993, 111:139-143.
100. Masuoka T., Kamei C. Role of hippocampal H1 receptors in radial maze performance and hippocampal theta activity in rats. Brain Res Bull 2007, 73:231-237.
101. Masuoka T., Kamei C. The ameliorating effects of NMDA receptor agonists on histamine H1 antagonist-induced memory and hippocampal theta disruptions are prevented by the H3 receptor agonist in rats. Brain Res Bull 2009, 79:422-425.
102. Masuoka T., Mikami A., Yasuda M., Shinomiya K., Kamei C. Effects of histamine H(1) receptor antagonists on hippocampal theta rhythm during spatial memory performance in rats. Eur J Pharmacol 2007, 576:77-82.
103. Masuoka T., Saito S., Kamei C. Participation of hippocampal ionotropic glutamate receptors in histamine H(1) antagonist-induced memory deficit in rats. Psychopharmacology (Berl) 2008, 197:107-114.
104. Mattioli R., Nelson C.A., Huston J.P., Spieler R.E. Conditioned place-preference analysis in the goldfish with the H1 histamine antagonist chlorpheniramine. Brain Res Bull 1998, 45:41-44.
105. Mazurkiewicz-Kwilecki I., Nsonwah S. The influence of alpha-fluoromethylhistidine on the regional brain histamine and plasma corticosterone levels in aging. Can J Physiol Pharmacol 1987, 65:2154-2157.
106. Mazurkiewicz-Kwilecki I.M., Prell G.D. Age-related changes in brain histamine. Agents Actions 1984, 14:554-557.
107. Medhurst A.D., Briggs M.A., Bruton G., Calver A.R., Chessell I., Crook B., et al. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats. Biochem Pharmacol 2007, 73:1182-1194.
108. Miller D.B., O'Callaghan J.P. The pharmacology of wakefulness. Metabolism 2006, 55:S13-S19.
109. Morisset S., Traiffort E., Schwartz J.C. Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity. Eur J Pharmacol 1996, 315:R1-R2.
110. Musiał A., Bajda M., Malawska B. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem 2007, 14:2654-2679.
111. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., et al. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci Lett 1993, 151:196-199.
112. Nakazato E., Yamamoto T., Ohno M., Watanabe S. Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamine H1 receptor blockade in rats. Life Sci 2000, 67:1139-1147.
113. Nishibori M., Oishi R., Itoh Y., Saeki K. 9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase. Jpn J Pharmacol 1991, 55:539-546.
114. Nishiga M., Fujii Y., Konishi M., Hossen M.A., Chiaki, Kamei Effects of second-generation histamine H1 receptor antagonists on the active avoidance response in rats. Clin Exp Pharmacol Physiol 2003, 30:60-63.
115. Nishiga M., Kamei C. Ameliorative effects of histamine on 7-chlorokynurenic acid-induced spatial memory deficits in rats. Psychopharmacology (Berl) 2003, 166:360-365.
116. Nishiga M., Sugimoto Y., Taga C., Fujii Y., Kamei C. Effects of the NMDA antagonist MK-801 on radial maze performance in histidine-deficient rats. Life Sci 2002, 70:2199-2208.
117. Nuutinen S., Karlstedt K., Aitta-Aho T., Korpi E.R., Panula P. Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology (Berl) 2010, 208:75-86.
118. Ohtsu H., Tanaka S., Terui T., Hori Y., Makabe-Kobayashi Y., Pejler G., et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 2001, 502:53-56.
119. Oishi R., Shishido S., Yamori M., Saeki K. Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 1994, 349:140-144.
120. Onodera K., Miyazaki S., Imaizumi M. Cognitive involvement by negative modulation of histamine H2 receptors in passive avoidance task in mice. Methods Find Exp Clin Pharmacol 1998, 20:307-310.
121. Orsetti M., Ferretti C., Gamalero R., Ghi P. Histamine H3-receptor blockade in the rat nucleus basalis magnocellularis improves place recognition memory. Psychopharmacology (Berl) 2002, 159:133-137.
122. Ovsepian S.V., Anwyl R., Rowan M.J. Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study. Eur J Neurosci 2004, 20:1267-1275.
123. Panula P., Rinne J., Kuokkanen K., Eriksson K.S., Sallmen T., Kalimo H., et al. Neuronal histamine deficit in Alzheimer's disease. Neuroscience 1998, 82:993-997.
124. Parmentier R., Ohtsu H., Djebbara-Hannas Z., Valatx J.L., Watanabe T., Lin J.S. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002, 22:7695-7711.
125. Pascoli V., Boer-Saccomani C., Hermant J.F. H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval. Psychopharmacology (Berl) 2009, 202:141-152.
126. Privou C., Li J.S., Hasenöhrl R.U., Huston J.P. Enhanced learning by posttrial injection of H1-but not H2-histaminergic antagonists into the nucleus basalis magnocellularis region. Neurobiol Learn Mem 1999, 71:308-324.
127. Rassnick S., Kornetsky C. L-histidine attenuates the effects of pentazocine on rewarding brain-stimulation. Life Sci 1991, 48:1729-1736.
128. Rinne J.O., Anichtchik O.V., Eriksson K.S., Kaslin J., Tuomisto L., Kalimo H., et al. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 2002, 81:954-960.
129. Rizk A., Curley J., Robertson J., Raber J. Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neurosci 2004, 19:1992-1996.
130. Sakai N., Sakurai E., Sakurai E., Yanai K., Mirua Y., Watanabe T. Depletion of brain histamine induced by alpha-fluoromethylhistidine enhances radial maze performance in rats with modulation of brain amino acid levels. Life Sci 1998, 62:989-994.
131. Saper C.B., German D.C. Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 1987, 74:364-370.
132. Sarazin M., Berr C., De Rotrou J., Fabrigoule C., Pasquier F., Legrain S., et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007, 69:1859-6187.
133. Selbach O., Brown R.E., Haas H.L. Long-term increase of hippocampal excitability by histamine and cyclic AMP. Neuropharmacology 1997, 36:1539-1548.
134. Selkoe D.J., Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003, 43:545-584.
135. Shannon H.E., Su T.P. Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels. Pharmacol Biochem Behav 1982, 17:789-795.
136. Shin N., Coates E., Murgolo N.J., Morse K.L., Bayne M., Strader C.D., et al. Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor. Mol Pharmacol 2002, 62:38-47.
137. Stocking E.M., Letavic M.A. Histamine H3 antagonists as wake-promoting and pro-cognitive agents. Curr Top Med Chem 2008, 8:988-1002.
138. Suzuki T., Mori T., Tsuji M., Nomura M., Misawa M., Onodera K. Evaluation of the histamine H1-antagonist-induced place preference in rats. Jpn J Pharmacol 1999, 81:332-338.
139. Suzuki T., Takamori K., Misawa M., Onodera K. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res 1995, 675:195-202.
140. Taga C., Sugimoto Y., Nishiga M., Fujii Y., Kamei C. Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats. Eur J Pharmacol 2001, 423:167-170.
141. Tashiro M., Mochizuki H., Iwabuchi K., Sakurada Y., Itoh M., Watanabe T., et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci 2002, 72:409-414.
142. Toyota H., Dugovic C., Koehl M., Laposky A.D., Weber C., Ngo K., et al. Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol 2002, 62:389-397.
143. Traub R.D., Bibbig A., LeBeau F.E., Buhl E.H., Whittington M.A. Cellular mechanisms of neuronal population oscillations in the hippocampus in vitro. Annu Rev Neurosci 2004, 27:247-278.
144. Unterwald E.M., Kucharski L.T., Williams J.E., Kornetsky C. Tripelennamine: enhancement of brain-stimulation reward. Life Sci 1984, 34:149-153.
145. van Ruitenbeek P., Vermeeren A., Riedel W. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. J Psychopharmacol 2008, 22:663-672.
146. Vorobjev V.S., Sharonova I.N., Walsh I.B., Haas H.L. Histamine potentiates N-methyl-D-aspartate responses in acutely isolated hippocampal neurons. Neuron 1993, 11:837-844.
147. Wada H., Inagaki N., Itowi N., Yamatodani A. Histaminergic neuron system in the brain: distribution and possible functions. Brain Res Bull 1991, 27:367-370.
148. Wagner U., Segura-Torres P., Weiler T., Huston J.P. The tuberomammillary nucleus region as a reinforcement inhibiting substrate: facilitation of ipsihypothalamic self-stimulation by unilateral ibotenic acid lesions. Brain Res 1993, 613:269-274.
149. Watanabe T., Taguchi Y., Shiosaka S., Tanaka J., Kubota H., Terano Y., et al. Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984, 295:13-25.
150. Weiler H.T., Steiner H., Huston J.P. Plasticity in crossed and uncrossed tuberomammillary-striatal projections in relation to recovery from behavioral asymmetries induced by hemivibrissotomy. Neuroscience 1990, 37:463-469.
151. Westerink B.H., Cremers T.I., De Vries J.B., Liefers H., Tran N., De Boer P. Evidence for activation of histamine H3 autoreceptors during handling stress in the prefrontal cortex of the rat. Synapse 2002, 43:238-243.
152. Williams K. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. Mol Pharmacol 1994, 46:531-541.
153. Wise R.A. Cocaine reward and cocaine craving: the role of dopamine in perspective. NIDA Res Monogr 1994, 145:191-206.
154. Xu L.S., Fan Y.Y., He P., Zhang W.P., Hu W.W., Chen Z. Ameliorative effects of histamine on spatial memory deficits induced by scopolamine infusion into bilateral dorsal or ventral hippocampus as evaluated by the radial arm maze task. Clin Exp Pharmacol Physiol 2009, 36:816-821.
155. Xu L.S., Yang L.X., Hu W.W., Yu X., Ma L., Liu L.Y., et al. Histamine ameliorates spatial memory deficits induced by MK-801 infusion into ventral hippocampus as evaluated by radial maze task in rats. Acta Pharmacol Sin 2005, 26:1448-1453.
156. Yamamoto Y., Mikami A., Fujii Y., Kamei C. Effect of histamine on muscimol-induced working memory deficits in radial maze performance. J Pharmacol Sci 2007, 104:252-257.
157. Yanai K., Son L.Z., Endou M., Sakurai E., Nakagawasai O., Tadano T., et al. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience 1998, 87:479-487.
158. Yanai K., Son L.Z., Endou M., Sakurai E., Watanabe T. Targeting disruption of histamine H1 receptors in mice: behavioral and neurochemical characterization. Life Sci 1998, 62:1607-1610.
159. Yanovsky Y., Haas H.L. Histamine increases the bursting activity of pyramidal cells in the CA3 region of mouse hippocampus. Neurosci Lett 1998, 240:110-112.
160. Yu C., Shen Y., Xu L., Zhu Y., Zhuge Z., Huang Y., et al. Effect of endogenous histamine in the ventral hippocampus on fear memory deficits induced by scopolamine as evaluated by step-through avoidance response in rats. Physiol Behav 2006, 87:687-693.
161. Zarrindast M.R., Ahmadi R., Oryan S., Parivar K., Haeri-Rohani A. Effects of alpha-adrenoceptor agonists and antagonists on histamine-induced impairment of memory retention of passive avoidance learning in rats. Eur J Pharmacol 2002, 454:193-198.
162. Zarrindast M.R., Parsaei L., Ahmadi S. Repeated administration of histamine improves memory retrieval of inhibitory avoidance by lithium in mice. Pharmacology 2008, 81:187-194.
163. Zimmermann P., Privou C., Huston J.P. Differential sensitivity of the caudal and rostral nucleus accumbens to the rewarding effects of a H1-histaminergic receptor blocker as measured with place-preference and self-stimulation behavior. Neuroscience 1999, 94:93-103.
164. Zimmermann P.K., Privou C., Wagner U., Huston J.P. Lateralized attenuation of hypothalamic self-stimulation after injecting histamine synthesis blocker alpha-FMH into the E2 tuberomammillary subnucleus. Brain Res Bull 1997, 44:85-90.
165. Zlomuzica A., Ruocco L.A., Sadile A.G., Huston J.P., Dere E. Histamine H1 receptor knockout mice exhibit impaired spatial memory in the eight-arm radial maze. Br J Pharmacol 2009, 157:86-91.
166. Zlomuzica A., Viggiano D., De Souza Silva M.A., Ishizuka T., Gironi Carnevale U.A., Ruocco L.A., et al. The histamine H1-receptor mediates the motivational effects of novelty. Eur J Neurosci 2008, 27:1461-1474.